PharmaCyte Biotech, Inc. Research And Development Expense

• PharmaCyte Biotech, Inc. showed an increase of +7.6% in Research And Development Expense from 2024 to 2025.
• This data is from PharmaCyte Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on August 11, 2025.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Historical annual values: Fiscal year 2025: $438.4 thousand | Fiscal year 2024: $407.4 thousand | Fiscal year 2023: $468.5 thousand | Fiscal year 2022: $690.9 thousand | Fiscal year 2021: $916.2 thousand | Fiscal year 2020: $301.2 thousand | Fiscal year 2019: $460.1 thousand | Fiscal year 2018: $2.00 million | Fiscal year 2017: $1.18 million | Fiscal year 2016: $1.41 million | Fiscal year 2015: $3.48 million | Fiscal year 2014: $323.5 thousand | Fiscal year 2013: $0.00.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026